Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

PURPOSE: Statins have antilymphoma properties but have also been shown to inhibit the binding of rituximab to the CD20 antigen, resulting in reduced antitumor activity of rituximab in vitro. The clinical impact of statin use on the outcome of lymphoma patients treated with a rituximab-containing reg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nowakowski, Grzegorz S., Maurer, Matthew J., Habermann, Thomas M., Ansell, Stephen M., Macon, William R., Ristow, Kay M., Allmer, Cristine, Slager, Susan L., Witzig, Thomas E., Cerhan, James R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815703/
https://ncbi.nlm.nih.gov/pubmed/20008638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.4245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados